Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Immunovia AB on track regarding application for listing on Nasdaq Stockholm’s main market

As previously announced, the company’s preparations of internal processes to meet the requirements on Nasdaq Stockholm’s main market were expected to be completed in September for initiation of the formal listing process. This goal has been achieved and Nasdaq reviews and formal processes will now follow as planned with the goal to list the company on Nasdaq Stockholm’s main market.For more information, please contact:Mats GrahnChief Executive Officer, CEO, ImmunoviaTel.: +46-70-5320230Email: mats.grahn@immunovia.com  About Immunovia   Immunovia AB was founded in 2007 by

The positive mood in the industrial sector was visible in the more international nature of the Subcontracting Trade Fair

Visitors to the Subcontracting Trade Fair, held in Tampere last week, numbered 17,684. The trade fair had exhibitors from 20 countries. The next Subcontracting Trade Fair will be held on 25–27 September 2018, which will also mark the 30th anniversary of the event. Subcontracting 2018 will focus on productivity developments in manufacturing. AlihankintaHEAT, an event that highlights start-up companies, will be held next year as well and play an increasingly important role in the trade fair. Next autumn, the trade fair will also be visited by participants of the IFPSM World Summit 2018.“It

Following its successful rights issue, ExpreS2ion finalises the AdaptVac joint venture

Hørsholm, Denmark, October 2, 2017 – Today, ExpreS2ion Biotech Holding AB announces that the fully owned subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) and NextGen Vaccines ApS (“NextGen”) have finalised all agreements for the AdaptVac ApS (“AdaptVac”) joint venture following the successful share issue in August 2017. In addition, ExpreS2ion expects AdaptVac to release additional information on animal data and its primary breast cancer vaccine candidate within the following weeks.AdaptVac was formed to combine the unique ExpreS2 protein development and production platform with the

Nordic Waterproofing Holding A/S’s nomination committee appointed

Nordic Waterproofing Holding A/S’s nomination committee ahead of 2018 Annual General Meeting has been appointed, based on ownership data as per 31 August 2017.The Annual General Meeting, held on the 27 April 2017, resolved that Nordic Waterproofing’s nomination committee shall be composed of members appointed by the four largest shareholders, who have expressed a wish to participate, and the chairman of the company. In accordance with shareholders’ decision, the nomination committee has been appointed and is composed by five members in total. Viktor Henriksson, Carnegie Funds, chairman

Invitation to the presentation of Axfood’s interim report for the third quarter 2017

Axfood invites you to a presentation of the interim report for the third quarter 2017 at 9:30 am CET on October 19. The interim report will be published at 7:00 am CET on the same day.Axfood’s President and CEO Klas Balkow will present together with CFO Anders Lexmon in a conference call. The presentation is held in English. Time: Thursday October 19, at 9:30 pm CET Venue: Hemköp’s “Rekobutik” store at Torsplan (Norra Stationsgatan 80A, street level to the right of the Hemköp entrance.) Telephone numbers: Sweden: +46 8 566 426 66UK: +44 203 0089 804US: +1 855 8315 945 The

Cleantech Invest agrees on its first debt for future investments

Until now the company has only used equity capital for investments but portfolio company revenues have during the last period grown to a level where Cleantech Invest now sees it fit to raise its first debt capital, via a credit line of 1MEUR from Nordea Bank. In the strategy update published earlier this year Cleantech Invest stated that the company is continuously evaluating possibilities for additional value creation through internal corporate restructuring such as demergers and return of capital, as well as balance sheet restucturing. CEO Alexander Lidgren: ”Since Cleantech

UPDATED UNAUDITED FINANCIAL INFORMATION PROVIDED TO THE HIGH COURT OF THE REPUBLIC OF SINGAPORE

1. Introduction 1.1 The Board of Directors (the “Board”) of EMAS Offshore Limited (the “Company” and together with its subsidiaries, the “Group”) wishes to refer to the announcement released by the Company dated 26 September 2017 where the Company announced that the High Court of the Republic of Singapore (the “High Court”) had issued a Moratorium with respect to each of the Company, Emas Offshore Pte Ltd (“EOPL”), and Emas Offshore Services Pte. Ltd (“EMSS”) (the “Singapore Filing Entities”) pursuant to which, the High Court inter alia ordered the Singapore Filing

Valmet's polarized forming fabrics revolutionize water drainage in paper-making

Valmet Oyj's trade press release on October 2, 2017 at 11:00 a.m. EET Forming fabrics have an essential role in water drainage in the wire section of a paper machine. By introducing the new generation's polarized forming fabrics, Valmet revolutionized water drainage in the wire section. "Our polarized forming fabrics have been piloted in paper-machines for over a year now. After the polarized technology entered the market in 2016, we have seen its advantages through our customers' performance. The machines run cleaner, number of breaks is reduced, retention is higher, just to mention

SimCorp A/S – Share buyback program

On 24 August 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 7.5m, to be executed during the period from 24 August 2017 to 31 December 2017. The following transactions have been executed under the program:            Date                 Number of shares Average Amount (DKK)

Peikko receives a large order to a shopping center in Latvia

Peikko’s subsidiary in Lithuania, UAB Peikko Lietuva, has received a notable order to a construction of a shopping and entertainment center Akropole located in Riga, Latvia. The order comprises over 176 tons of PSB Punching Reinforcement, 100 tons of various fastening items, more than 3,000 pcs of bolted connections, and 3,500 tons of steel structures. The deliveries are ongoing and the project is estimated to be finished in 2019. The developer of the project is SIA M257 and Sarma & Norde Arhitekti is responsible for the architectural design. The main contractors of the

Cereno Scientific receives regulatory approval to start clinical study with its drug candidate CS1

Cereno Scientific (Aktietorget: “CRNO B”) announced today that the company has received approval from the Medical Products Agency (‘Läkemedelsverket’) and the Ethical Review Board (‘Etikprövningsnämnden’) in Uppsala, Sweden, to initiate the first clinical study of its drug candidate, CS1. The approval from the Medical Products Agency and the Ethical Review Board is the starting signal for a first clinical study with the drug candidate CS1, which Cereno Scientific has developed.The study will assess the safety and tolerability, as well as the pharmacokinetics of CS1 in adults with

Brunswick Real Estate forms Kielo, a real estate company investing in Finland, and completes its first acquisition

Helsinki, 2 October 2017 Brunswick Real Estate today announced the formation of Kielo, a real estate company aiming to acquire high quality commercial real estate in growing cities in Finland, together with its investors. Kielo has completed its first transaction acquiring a 40,000 sqm office property in Tampere from Aberdeen Standard Investment.Kielo’s investment mandate is broad and flexible, enabling the company to pursue opportunities in growing cities in Finland. The objective is to create a property portfolio in excess of EUR 1 billion over the coming years. Kielo’s investment

Enea OSE selected for 5G radio base station

Enea OSE will boost throughput and reduce latency in 5G baseband processingSTOCKHOLM, Sweden, October 2, 2017 – Enea® (Nasdaq Stockholm: ENEA), a global supplier of network software platforms and world class services, today announced that it has been selected by an Asian tier one telecom equipment manufacturer (TEM), to deliver its 64-bit Enea OSE multicore operating system for use in time-critical functions in a line of 5G radio base stations. Enea OSE was chosen based on its ability to combine high throughput with low latency on multicore processors. In the design, Enea OSE will

Q-FREE – SHARE OPTIONS GRANTS

Q-Free ASA has granted a total of 1 392 053 share options to the following primary insiders, in accordance with the incentive program for leading executives adopted by the General Meeting 24 May 2017. Tor Eirik Knutsen, CFO, has been granted 258 216 share options with a strike price of NOK 8.52, 184 440 share options with a strike price of NOK 11.93, and 151 892 share options with a strike price of NOK 14.48. Knutsen has no shares in Q-Free ASA. Fredrik Nordh, SVP Europe, has been granted 228 991 share options with a strike price of NOK 8.52, 163 565 share options with a strike price

Professor Fredrik Höök purchases an Acoulyte instrument and becomes reference center for Insplorion within bio applications

Fredrik Höök, professor in Biological Physics at the Department of Physics, Chalmers University of Technology, becomes a customer to Insplorion and an Acoulyte user within a reference center collaboration. Prof. Höök and his group are leading researchers in drug delivery systems and molecular interactions with cell surfaces. Höök is also one of the founders of Q-Sense and is an expert on the acoustic QCM-D technology that Insplorion's optical NPS technology is combined with using the Acoulyte instrument. The solid knowledge in both life science and QCM-D makes Fredrik Höök's group a very

Victoria Park’s Nomination Committee ahead of 2018 AGM appointed

According to a motion passed at the 2017 Annual General Meeting (AGM) of Victoria Park AB shareholders, the four largest shareholders in terms of voting power are to be invited to appoint members of the Nomination Committee ahead of the 2018 AGM. Those who are appointed by these shareholders, together with the Chairman of the Board as the convener, shall constitute the company’s Nomination Committee. Ahead of the 2018 AGM, Victoria Park’s Nomination Committee consists of Greg Dingizian and Anders Pettersson, based on their own mandate, Gillis Cullin based on the mandate of the Foundation

Medals of War featured by Apple

Nitro Games’ latest game “Medals of War” is currently featured by Apple on App Store.Medals of War is currently featured by Apple in the ”New Games We Love” -category on the front page of the App Store in 18 countries, including United States. "We’re delighted to get this visibility for Medals of War from Apple. This is our first big self-published game and that makes us feel proud of this recognition. We see this as yet another validation that we’re on the right path with our MVP process and with Medals of War.”  says Jussi Tähtinen, CEO and Co-Founder, Nitro Games Oyj. Medals of War

Atlas Copco wins orders in Kazakhstan for highly productive mining operations

Stockholm, Sweden, October 2, 2017: Atlas Copco, a leading provider of sustainable productivity solutions, has won recent orders from Kazakhmys Corporation, a leading copper producer in Kazakhstan. The mining equipment will enhance the customer’s productivity, safety and ergonomics.The orders include dozens of mine trucks, loaders and drilling rigs for use in 11 mines, including the major Zhomart copper and silver mine in Central Kazakhstan. The orders total MEUR 22.5 (MSEK 215) and were received in the second and third quarters of 2017.  Equipment delivery has started and will continue

Rörgruppen to carry out heating and plumbing installations in NCC’s new head office

Instalco’s subsidiary Rörgruppen has been awarded a contract to carry out heating and plumbing installations in NCC’s new head office in Solna. The order value amounts to approximately SEK 50 million.The head office will be built in Järva Krog, Solna, and represents the start of a major development of the area, where three new city blocks with offices, restaurants, service and residential properties are planned. The building where NCC's head office will be located consists of approximately 20,000 square meters of leasable area and is expected to be completed in 2019. “We are happy and

Selvaag Bolig ASA: invitation to capital markets update

Selvaag Bolig ASA is pleased to invite investors, analysts, media and other stakeholders to a capital markets update on Thursday 9 November 2017 in Oslo. We will provide an update on our strategy and financial development, and discuss the market and company outlook. Our third-quarter results will be released on the same day and presented at the event. Presentations will be given by CEO Baard Schumann, CFO Sverre Molvik and Nejra Macic from Prognosesenteret, an independent market analysis company which specialises in the Nordic construction and property markets. Directors of our

Orexo signs asset purchase agreement with Gesynta Pharma AB for OX-MPI

Uppsala, Sweden – October 2, 2017 – Orexo AB (publ.) today announced that Orexo has signed an asset purchase agreement with Gesynta Pharma AB – a recently formed research company located in Stockholm, Sweden. Among the founders are highly reputed executives from the biotech industry and experienced researchers at the Karolinska Institute within the field of arachidonic acid pathways and inflammatory diseases. The lead candidate drug in the OX-MPI program, BI1029539, has been identified as a highly selective anti-inflammatory compound targeting microsomal prostaglandin E synthase (mPGES-1).

The combined Intrum Justitia and Lindorff becomes Intrum

On June 27th 2017, the combination of Intrum Justitia and Lindorff was completed, creating the leading provider of credit management services (CMS). Today, the company takes an important step towards consolidating the two companies by introducing a new corporate identity and brand name. ”Intrum is the undisputed market leader. This presents new opportunities for growth through joined resources, broader geographical presence and increased financial strengths to be able to make investments to secure long term added value for all our stakeholders. To best make use of these opportunities we

Phase I extension study demonstrates beneficial effects on lipid metabolism with C21

Vicore Pharma AB (publ) (ticker: VICO) can today announce positive results from the in-depth analysis of the Phase I extension study with its candidate drug named C21.The extension study, initiated in January 2017, was performed on a group of overweight (BMI 30-35 and waist-to-hip ratio (WHR) above 0.9) but otherwise healthy men. In total 16 volunteers participated, whereof 8 were given 100 mg C21 in a once daily dose and 8 were given placebo over a period of 8 days. The aim of the study was to evaluate safety and tolerability of C21 in a group with a potentially compromised metabolic

There are no items matching the current filter
There are no more items matching the current filter
Back to top